Author:
Ferreira Débora,Silva Renata,Figueiredo Laura,Rodrigues Ligia
Publisher
Springer International Publishing
Reference107 articles.
1. Abdellatif AAH, Hennig R, Pollinger K, Tawfeek HM, Bouazzaoui A, Goepferich A (2020) Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment. Pharm Res 37:217. https://doi.org/10.1007/s11095-020-02938-1
2. Abdellatif AA, Abdelhafez WA, Sarhan HA (2018) Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors., Iran. J. Pharm. Res. IJPR. 17 (2018) 513–524. http://www.ncbi.nlm.nih.gov/pubmed/29881409
3. Alavi N, Rezaei M, Maghami P, Fanipakdel A, Avan A (2022) Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin. Curr Cancer Drug Targets 22:361–372. https://doi.org/10.2174/1568009622666220120115140
4. Arruebo M, Valladares M, González-Fernández Á (2009) Antibody-Conjugated Nanoparticles for Biomedical Applications. J Nanomater 2009:1–24. https://doi.org/10.1155/2009/439389
5. Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Milowsky MI, Posadas EM, Ryan CJ, Graf RP, Dittamore R, Schreiber NA, Summa JM, Youssoufian H, Morris MJ, Scher HI (2018) Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Oncol 4:1344. https://doi.org/10.1001/jamaoncol.2018.2168